Brandi G.; Relli V.; Deserti M.; Palloni A.; Indio V.; Astolfi A.; Serravalle S.; Mattiaccio A.; Vasuri F.; Malvi D.; Deiana C.; Pantaleo M.A.; Cescon M.; Rizzo A.; Katoh M.; Tavolari S., Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies, «SCIENTIFIC REPORTS», 2024, 14, Article number: 3136 , pp. 1 - 10 [Scientific article]Open Access
Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S., Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1137510 , pp. 1 - 10 [Scientific article]Open Access
De Giglio A.; Deiana C.; Di Federico A., Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2023, 149, pp. 1835 - 1847 [Scientific article]Open Access
Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A., Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review, «LUNG CANCER: TARGETS AND THERAPY», 2023, 14, pp. 11 - 25 [Scientific article]
Deiana, C.; Fabbri, F.; Tavolari, S.; Palloni, A.; Brandi, G., Improvements in Systemic Therapies for Advanced Malignant Mesothelioma, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, pp. 10415 - 10436 [Scientific article]Open Access
De Giglio A.; Di Federico A.; Deiana C.; Ricciuti B.; Brambilla M.; Metro G., Advanced non-small-cell lung cancer: how to manage non-oncogene disease, «DRUGS IN CONTEXT», 2022, 11, Article number: 2022-2-4 , pp. 1 - 14 [Scientific article]Open Access
Di Federico, A.; Nuvola, G.; Deiana, C.; Donati, G.; De Giglio, A., IMpower 132: Is the Second Exception to the Rule No Longer an Exception?, «JOURNAL OF THORACIC ONCOLOGY», 2021, 16, pp. 29 - 30 [Scientific article]
Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A., PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis, «FUTURE ONCOLOGY», 2021, 17, pp. 4415 - 4424 [Scientific article]
De Giglio, A.; Di Federico, A.; Nuvola, G.; Deiana, C.; Gelsomino, F., The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines), «CURRENT ONCOLOGY REPORTS», 2021, 23, pp. 1 - 15 [Scientific article]
